Q3 2025 Holdings
Filed 2025-11-14 | 17 holdings | $456.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $68.0M | 801,224 | 14.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $62.6M | 4,604,878 | 13.7% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $39.6M | 300,610 | 8.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $33.8M | 2,674,469 | 7.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $29.1M | 2,025,041 | 6.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $28.4M | 788,441 | 6.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $23.4M | 473,828 | 5.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $23.4M | 579,895 | 5.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $22.5M | 340,897 | 4.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.1M | 886,332 | 4.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $20.2M | 503,701 | 4.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $17.8M | 734,539 | 3.9% |
| Merus N V | COM | N5749R100 | $17.3M | 184,135 | 3.8% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $17.1M | 368,176 | 3.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $13.5M | 1,151,686 | 3.0% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $12.7M | 155,370 | 2.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $4.4M | 153,147 | 1.0% |